Company to sell some medicines at a discount to US’s Medicaid health plan in exchange for tariff relief

Donald Trump announced a deal with the British-based drugmaker AstraZeneca for a “most-favored-nation” drug-pricing model aimed at making prescription medicines more affordable and avoiding the administration’s tariff threats.

The company will sell some medicines at a discount to the government’s Medicaid health plan in exchange for tariff relief, similar to a drug-pricing pact reached last week with Pfizer.